Paul Brooks is the founder of CN Bio. Latest round: Series B. Backed by Bayland Capital, CN Innovations Holdings Ltd. Based in Cambridge, United Kingdom.
Paul Brooks is the Chief Executive Officer of CN Bio Innovations, a Cambridge-based company that develops Organ-on-a-Chip microphysiological systems for drug discovery. He is instrumental in securing significant funding, including a $21 million first close of Series B in April 2024, to turn drug discovery models into practical decision-making tools for the pharmaceutical industry.
Full founder directory · Investor directory · Company funding database · Fundraising library